Bangladesh vs Senegal: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Bangladesh
0.4%
in 2024
Senegal
0.4%
in 2024
Bangladesh rank
74th
Senegal rank
74th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Bangladesh
- Senegal
How they compare
Bangladesh currently reports 0.4% against 0.4% in Senegal, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Senegal ahead.
Bangladesh ranks 74th and Senegal ranks 74th of 246 countries.
Across the 2 decades both report, Bangladesh averaged higher in 1 and Senegal in 1.
Head to head by decade
| Decade | Bangladesh | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.7% | 0.8% | 0.2% | Senegal |
| 2020s | 0.5% | 0.5% | 0.0% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Bangladesh or Senegal?
- Bangladesh, at 0.4% against 0.4% in Senegal as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Bangladesh and Senegal?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Senegal?
- 10 years are reported by both, from 2015 to 2024.
- How do Bangladesh and Senegal rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Bangladesh ranks 74th and Senegal ranks 74th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.